Cardiovascular devices are medical devices used to diagnose and treat cardiovascular diseases, which are conditions that affect the heart and blood vessels. These devices are critical for the treatment of patients with heart disease, as they can help improve heart function, reduce symptoms, and prevent complications. The cardiovascular devices market in Germany is likely to register a CAGR of over 5.4% with an incremental growth of USD 1.4 billion during the forecast period 2023-2029.
This industry report offers market estimates of the Germany market, followed by a detailed analysis of the product. The Germany market data on cardiovascular devices can be segmented by product: aortic and vascular graft devices, atherectomy devices, cardiac assist devices, cardiac rhythm management devices, cardiovascular prosthetic devices, cardiovascular surgery devices, clot management devices, electrophysiology devices, interventional cardiology, peripheral vascular devices, prosthetic heart valves. In 2022, the interventional cardiology segment made up the largest share of revenue generated by the cardiovascular devices market.
The Germany cardiovascular devices market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Abbott Laboratories, Abiomed Inc, B. Braun Melsungen AG, Biosense Webster Inc, Biotronik AG, Boston Scientific Corporation, C. R. Bard Inc., Cook Medical Inc, Edwards Lifesciences Corporation, Koninklijke Philips N.V., LivaNova PLC, MAQUET Holding B.V. & Co. KG, Medtronic Plc, MicroPort Scientific Corporation, Terumo Corporation, W. L. Gore & Associates Inc.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive coverage of the market across different market segments, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
▹ Get a detailed picture of the Germany Cardiovascular Devices Market
▹ Identify segments/areas to invest in over the forecast period in the Germany Cardiovascular Devices Market
▹ Understand the competitive environment, the market's leading players
▹ The market estimate for ease of analysis across scenarios in Excel format.
▹ Strategy consulting and research support for three months.
▹ Print authentication provided for the single-user license.
Part 1. Summary
Part 2. Introduction
Study period
Geographical scope
Market segmentation
Part 3. Cardiovascular devices market overview
Part 4. Market breakdown by product
Aortic and vascular graft devices
Atherectomy devices
Cardiac assist devices
Cardiac rhythm management devices
Cardiovascular prosthetic devices
Cardiovascular surgery devices
Clot management devices
Electrophysiology devices
Interventional cardiology
Peripheral vascular devices
Prosthetic heart valves
Part 5. Key companies
Abbott Laboratories
Abiomed Inc
B. Braun Melsungen AG
Biosense Webster Inc
Biotronik AG
Boston Scientific Corporation
C. R. Bard, Inc.
Cook Medical Inc
Edwards Lifesciences Corporation
Koninklijke Philips N.V.
LivaNova PLC
MAQUET Holding B.V. & Co. KG
Medtronic Plc
MicroPort Scientific Corporation
Terumo Corporation
W. L. Gore & Associates, Inc.
Part 6. Methodology
The Medical Devices Secondary Packaging Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...
Market Overview
The Asia Pacific Vascular Closure Devices Market is anticipated to experience substantial growth from 2024 to 2034. The market's expansion is fueled by advancements in vascular closure technologies, increasing prevalence of cardiovascular diseases, and the growing adopti...
Market Overview
The Europe Vascular Closure Devices Market is poised for significant growth from 2024 to 2034, driven by advancements in minimally invasive procedures, increasing procedural volumes, and a growing preference for vascular closure solutions that enhance patient outcomes. T...
Market Overview
The North America Vascular Closure Devices (VCD) Market is anticipated to witness significant growth from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures, rising prevalence of cardiovascular diseases, and advancements in vasc...
Market Overview
The Global Vascular Closure Devices Market is projected to grow substantially from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures and the rising demand for fast, efficient vascular closure solutions. In 2024, the market is v...
Market Overview
The Asia Pacific Wi-Fi Chipset Market is on a trajectory of significant expansion from 2024 to 2034, driven by the increasing demand for high-speed wireless connectivity, advancements in Wi-Fi technologies, and the proliferation of connected devices. The market is antici...
Market Overview
The Europe Wi-Fi Chipset Market is expected to witness robust growth from 2024 to 2034, driven by the increasing demand for high-speed internet connectivity and the proliferation of connected devices. The market is projected to reach USD XX.XX billion by 2034, growing at...
Market Overview
The North America Wi-Fi Chipset Market is poised for substantial growth from 2024 to 2034, driven by the increasing demand for high-speed internet connectivity, the proliferation of smart devices, and advancements in Wi-Fi technology. By 2034, the market is projected to ...
Market Overview
The Global Wi-Fi Chipset Market is poised for significant growth from 2024 to 2034, driven by the increasing adoption of wireless communication technologies across various industries. Valued at USD XX.XX billion in 2024, the market is projected to reach USD XX.XX billion...
Market Overview
The Asia Pacific Sleep Apnea Implants Market is set for substantial growth from 2024 to 2034, driven by increasing prevalence of sleep apnea disorders, advancements in implant technologies, and rising healthcare expenditure in the region. The market is anticipated to rea...